Michaela Medová - Concepedia

Author

Michaela Medová

Also Known As

M Medova, M. Medova, M. Medovà, M. Medová, Medova, M., Medova, Michaela, Michaela Medova, Michaela Medová, Michaela Medová, Ng, Charlotte K. Y.

197

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

University of Bern University Hospital of Bern Merck (Germany)Bern University of Applied Sciences University Hospital of Basel

About

Michaela Medová is an author at University of Bern specializing in medicine, cell biology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	356
2	Cell Biology	9	9	320
3	Health Sciences	2	2	69
4	Natural Sciences	1	1	20
5	Biochemistry	1	1	20

Michaela Medová

Publications

766

Citations

H-Index

Page 1

	Year	Citations
MET Inhibition Results in DNA Breaks and Synergistically Sensitizes Tumor Cells to DNA-Damaging Agents Potentially by Breaching a Damage-Induced Checkpoint Arrest Michaela Medová, Daniel M. Aebersold, Wieslawa Blank-Liss, Genes & Cancer Dna DamageRadiation EffectApoptosisMolecular BiologyCell Death	2010	70
Verteporfin-induced lysosomal compartment dysregulation potentiates the effect of sorafenib in hepatocellular carcinoma Jacopo Gavini, Noëlle Dommann, Manuel O. Jakob, Cell Death and Disease	2019	68
MET inhibition in tumor cells by PHA665752 impairs homologous recombination repair of DNA double strand breaks Michaela Medová, Daniel M. Aebersold, Yitzhak Zimmer International Journal of Cancer ChromatinGenome InstabilityDna DamageMedicineMolecular Biology	2011	56
Hsp90 transcriptionally and post-translationally regulates the expression of NDRG1 and maintains the stability of its modifying kinase GSK3β Vanessa Banz, Michaela Medová, Adrian Keogh, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research Kinase Gsk3βTranscriptional RegulationSignal TransductionCell RegulationMolecular Pathway	2009	49
The Molecular Crosstalk between the MET Receptor Tyrosine Kinase and the DNA Damage Response—Biological and Clinical Aspects Michaela Medová, Daniel M. Aebersold, Yitzhak Zimmer Cancers Radiation EffectRadiation ExposureMolecular BiologyRadiation BiologyTumor Biology	2013	40
Hepatocyte growth factor secreted by bone marrow stem cell reduce ER stress and improves repair in alveolar epithelial II cells Katrin Hostettler, Luca Tamò, Michaela Medová, Scientific Reports	2017	35
Impact of p53 Status on Radiosensitization of Tumor Cells by MET Inhibition–Associated Checkpoint Abrogation Kei Mikami, Michaela Medová, Lluís Nisa, Molecular Cancer Research	2015	32
Comprehensive Genomic Profiling of Patient-matched Head and Neck Cancer Cells: A Preclinical Pipeline for Metastatic and Recurrent Disease Lluís Nisa, David Barras, Michaela Medová, Molecular Cancer Research	2018	31
Protective autophagy is involved in resistance towards MET inhibitors in human gastric adenocarcinoma cells Magali Humbert, Michaela Medová, Daniel M. Aebersold, Biochemical and Biophysical Research Communications Cell AutophagyMitophagyChemoprevention StrategyMedicineProtective Autophagy	2013	30
The Novel ATP-Competitive Inhibitor of the MET Hepatocyte Growth Factor Receptor EMD1214063 Displays Inhibitory Activity against Selected MET-Mutated Variants Michaela Medová, Benoît Pochon, Bruno Streit, Molecular Cancer Therapeutics Emd1214063 TreatmentCancer BiologyTumor BiologySignaling PathwayReceptor Tyrosine Kinase	2013	29

Page 1